Improving Sleep, Fatigue, Activity & Quality of Life in Cancer Survivors
This study is testing a program called the Transdiagnostic Sleep Health Intervention (TSHI) to help cancer survivors with sleep problems. Many cancer survivors experience poor sleep, which can lead to fatigue and lower quality of life, even if they don't have a diagnosed sleep disorder. The TSHI program aims to improve different aspects of sleep, such as how regular, satisfying, and efficient your sleep is. You would meet with a sleep expert online for six weekly sessions. This study is looking at whether this program is practical and acceptable, how easy it is to recruit participants, and how many people stay in the study. To join, you need to be at least 18 years old, have finished primary cancer treatment at least six months ago, and have internet access. You also need to have certain scores on questionnaires related to sleep, anxiety, and depression.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 12 participants.
- What's involved
- You would participate in six weekly 50-minute one-on-one sessions with a sleep expert via videoconference. The study will assess feasibility and acceptability after study week 7.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will assess outcomes after study week 7.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Sleep, Fatigue, Activity & Quality of Life in Cancer Survivors Via a Transdiagnostic Intervention
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility and acceptability of a videoconference-based Transdiagnostic Sleep Health InterventionAfter study week 7
TSHI acceptability will be assessed qualitatively and quantitatively following the study. Qualitative assessments will involve semi-structured interviews with each participant, guided by a written list of questions. Quantitative assessments of TSHI acceptability, usability, and usefulness will use a modified System Usability Scale (SUS). scores range from 0-100 with a higher score indicating better perceived usability of the intervention.
- RecruitmentAfter study week 7
The investigators will assess program feasibility via recruitment. Recruitment rates will be: # of cancer survivors enrolled ÷ # of cancer survivors who complete the screening survey. With a higher number indicating ease, practicality, and efficiency of the recruitment process.
- Study RetentionAfter study week 7
We will assess program feasibility via study retention. Study retention will be: # of cancer survivors completing the TSHI ÷ # of cancer survivors who began the TSHI. A high retention rate indicates the ability to keep participants committed over time, suggesting that the project is feasible and likely to succeed.
- Adherence RatesAfter study week 7
We will assess program feasibility via protocol adherence rates. Adherence will be: # of weekly videoconference-based TSHI sessions attended ÷ six (total number of TSHI sessions). A high adherence rate indicates that the study design is viable and participants are able and willing to follow the protocol.